Skip to main content
. 2022 Feb 25;64:e20. doi: 10.1590/S1678-9946202264020

Table 2. Significant variables for the severity of the patients admitted due to COVID-19 in the bivariate analysis.

Variable ICU/MV N (%)N = 225 (39.8) RR (95% CI) P-value
Age (years)
< 60 100 (33.0) 1
61 to 69 65 (48.1) 1.46 (1.15 to 1.85) 0.004
> 70 60 (47.2) 1.43 (1.12 to 1.83) 0.002
Comorbidities
Hypertension 122 (46.0) 1.34 (1.09 to 1.64) 0.005
Diabetes mellitus 78 (47.9) 1.31 (1.07 to 1.61) 0.010
Obesity 48 (53.3) 1.43 (1.14 to 1.79) 0.002
Neoplasia 24 (54.5) 1.41 (1.06 to 1.89) 0.020
Number of comorbidities
None 46 (26.3) 1
1 70 (42.7) 1.62 (1.20 to 2.20) 0.002
≥ 2 109 (48.2) 1.84 (1.38 to 2.43) < 0.001
Clinical alterations upon admission
Altered level of consciousness 45 (70.3) 1.96 (1.61 to 2.38) < 0.001
Vasoactive amines 29 (96.7) 2.64 (2.32 to 3.00) < 0.001
SpO2 < 93% 82 (71.3) 2.21 (1.85 to 2.65) < 0.001
SpO2/FiO2 Ratio ≤ 315 97 (84.3) 2.93 (2.48 to 3.47) < 0.001
Supplemental O2 requirement 130 (63.1) 2.39 (1.95 to 2.92) < 0.001
Laboratory and imaging tests upon admission
C-Reactive Protein > 100 mg/L 141 (56.6) 2.13 (1.71 to 2.66) < 0.001
Lactate (ABG) ≥ 1.6 mmol/L 74 (54.0) 1.44 (1.17 to 1,76) < 0.001
Troponin ≥ 14 ng/L 92 (53.8) 1.58 (1.27 to 1.98) < 0.001
Lymphocytes < 1,000 /Ul 123 (52.3) 1.70 (1.38 to 2.08) < 0.001
Urea ≥ 50 mg/dL 83 (53.9) 1.55 (1.27 to 1.90) < 0.001
Creatinine > 1.2 mg/dL 76 (52.8) 1.48 (1.21 to 1.81) < 0.001
GOT/AST ≥ 37 U/L 106 (42.7) 1.32 (1.01 to 1.73) 0.039
INR ≥ 1.3 64 (55.2) 1.44 (1.17 to 1.78) 0.001
Altered chest x-ray 189 (43.5) 2.00 (1.36 to 2.94) < 0.001
Need of NIV at some time during hospitalization 21 (87.5) 2.32 (1.93 to 2.80) < 0.001

Frequency (percentage); RR = Relative risk; CI = Confidence interval; O2 = oxygen; SpO2 = peripheral oxygen saturation; SpO2/FiO2 Ratio = the ratio between the peripheral oxygen saturation and the fraction of inspired oxygen; ABG = arterial blood gas; NIV = non-invasive ventilation.